Biotech Stock Roundup: Regulatory Updates From NVAX, BBIO Down on Drug Failure & More

Posted byZacks Equity Research Leave a comment on Biotech Stock Roundup: Regulatory Updates From NVAX, BBIO Down on Drug Failure & More

Regulatory and other pipeline updates from NVAX and BBIO are among a few key highlights from the biotech sector during the past week.

Leave a comment

Your email address will not be published. Required fields are marked *